Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 3012569 | HLA-D (HLA-D) | diseases | NA | NA | NA | unclassified | |
| the analysis of this polymorphism is crucial for (i) histocompatibility matching for transplantation and (ii) understanding the association between hla-d and certain important diseases. | |||||||
| 3044438 | HLA (HLA) | transplantation | NA | melphalan | NA | unclassified | |
| marrow transplantation from hla non-identical family donors for the treatment of leukaemia: a pilot study of 15 patients using additional immunosuppression and t-cell depletion. | |||||||
| 3044989 | HLA (HLA) | transplantation | European | NA | NA | unclassified | |
| results of transplantation of t-cell depleted bone marrow from an hla-haploidentical related donor were also excellent in infants with severe combined immunodeficiency, with 60% recovery. | |||||||
| 3044989 | HLA (HLA) | severe combined immunodeficiency | European | NA | NA | unclassified | |
| results of transplantation of t-cell depleted bone marrow from an hla-haploidentical related donor were also excellent in infants with severe combined immunodeficiency, with 60% recovery. | |||||||
| 3044989 | HLA (HLA) | transplantation | European | NA | NA | unclassified | |
| hla-haploidentical t-cell depleted marrow transplantation for other severe immunodeficiencies was less successful. | |||||||
| 3048467 | HLA IDENTICAL (HLA-IDENTICAL) | cyclophosphamide | NA | melphalan | NA | unclassified | |
| NA | |||||||
| 3048488 | HLA MISMATCHED (HLA-MISMATCHED) | transplantation | NA | NA | NA | unclassified | |
| alternative donor sources in hla-mismatched marrow transplantation: t cell depletion of surgically resected cadaveric marrow. | |||||||
| 3048488 | HLA MISMATCHED (HLA-MISMATCHED) | cadaver | NA | NA | NA | unclassified | |
| alternative donor sources in hla-mismatched marrow transplantation: t cell depletion of surgically resected cadaveric marrow. | |||||||
| 3048488 | HLA MATCHED (HLA-MATCHED) | transplantation | NA | NA | NA | unclassified | |
| t cells in the donor marrow generate graft-versus-host disease which is a major consideration in attempts to widen the application of allogeneic marrow transplantation to the minimally hla-matched or mismatched setting. | |||||||
| 3048488 | HLA MATCHED (HLA-MATCHED) | graft-versus-host disease | NA | NA | NA | unclassified | |
| t cells in the donor marrow generate graft-versus-host disease which is a major consideration in attempts to widen the application of allogeneic marrow transplantation to the minimally hla-matched or mismatched setting. | |||||||
Copyright 2024